Xenetic has allotted 80m acquisition shar...
You must be logged in to view the whole article.
Click here if you require signing up
Brazil adds IPV of Sanofi Pasteur in national immunisation programme
Vivalis, Sanofi Pasteur sign extension to 2010 vaccine collaboration
Pevion unveils positive data from Candida vaccine trial
Xenetic completes acquisition of SymbioTec
Intercell, SSI advance TB vaccine candidate into Phase II study
Nuron Biotech signs vaccine licensing agreement with Japan's MTPC
Advanced BioNutrition, Chile's Centrovet agree to expand ISAV vaccine
GSK appeals against Argentina court ruling on vaccine trial fine
Enrolment in Phase II prevention trial with Diamyd's diabetes vaccine finalised
Takeda, Osaka University join hands to advance nano-particle vaccines research
Profectus begins Phase I trial of rVSV-vectored HIV-1 vaccine
Novavax, Cadila JV prepares to launch influenza, rabies vaccines studies
Pfizer gains FDA nod to broaden indication of pneumococcal conjugate vaccine Prevnar 13